Mpirik
Leveraging AI to Deliver Superior Cardiac Care at Scale

In spite of large-scale deployment of integrated healthcare systems in the U.S and around the world, many patients with heart disease continue to experience significant delay in treatment. Late treatment potentially compromises patient outcomes and leads to excessive cost. The root cause of this issue is not the slow adoption of new technology but the way in which patient healthcare data is screened for accurate and timely diagnosis. To this day, even though a patient’s health status is recorded digitally via an Electronic Medical Record (EMR), the process of screening the data is manual. This leads to inconsistency in the diagnosis of a patient, which often leads to delay and further complications. Addressing this challenge with its unique cloud-based and HIPAA-compliant platform is Wisconsin-based Mpirik. The company’s platform is designed to help clinicians leverage the consistency of a computer algorithm and objectively screen patients with cardiovascular disorders at scale. “Our platform screens the EMR and other sources for critical cardiovascular disease. We make this live data immediately actionable for disease experts. The result is timely treatment and 100% accountability for all patients," says Dr. Daniel O’Hair, Chief Medical Officer at Mpirik.

As a practicing cardiovascular surgeon, Dr. O’Hair has firsthand experience in dealing with the inefficiencies of consolidating a patient’s health data from disparate healthcare systems. Mpirik’s Cardiac Intelligence™ platform is developed with the aim to eliminate the manual, cumbersome, and inefficient patient data screening processes and close the undertreatment gap to zero for heart valve disease. At the same time, to ensure a completely seamless experience for physicians, Mpirik’s platform is EMR-agnostic and compliant with the Health Level 7 (HL7) standards for the transfer of clinical and administrative data. Additionally, the platform leverages artificial intelligence (AI) and natural language processing (NLP) to analyze an echocardiogram and identify critical data points. Following this, the platform runs the data through its proprietary rule-based engines and issues a recommendation to the referring clinician to guide doctors to make decisions for treatment according to clinically validated guidelines.

In cases where a patient has a moderate cardiac condition, the platform keeps them under surveillance and notifies physicians if they miss a necessary follow-up consult or exam.

Furthermore, owing to its highly scalable cloud-based architecture, Mpirik’s Cardiac Intelligence^™ platform has already screened hundreds of thousands of patients. “We also run periodic audits as well as software and architecture penetration tests to ensure secure and continuous delivery of data-driven insights,” adds Logan Brigman, Chief Operating Officer at Mpirik. The Cardiac Intelligence^™ platform concurrently provides customizable dashboards that physicians and administrators can leverage to view real-time data analytics. And by utilizing this functionality, Mpirik is currently detecting and gathering critical data sets from real-world scenarios to pursue several research studies that can enhance clinicians’ understanding of a disease and it's treatment outcomes.

To this extent, Mpirik assigns a separate account manager for each of its clients that handles their day-to-day goals and strategies. The platform also offers a live chat feature where clinicians can directly connect with experts that aid them in resolving any platform-related inquiries. “We feel strongly about creating tight-knit relationships with our physician and administrative partners. They see immediate value as the platform ensures quality and enables organic growth by accounting for every patient,” states Dr. Joe Kohli, Founder and CEO.

With such unparalleled competencies, Mpirik has uncovered many remarkable case studies since its inception in 2013. Recently, the company assisted clinicians by identifying a 67-year old patient’s critical cardiac health status using its Cardiac Intelligence^™ platform. The patient had undergone heart valve replacement surgery in the distant past but was recently admitted for heart failure. The care team immediately began treating her heart failure but didn't fully appreciate how her valve had deteriorated since her last visit. Fortunately, Mpirik’s Cardiac Intelligence^™ platform identified a critical heart problem and notified the heart team. The patient had urgent surgery and now has made a complete recovery.

Mpirik has continually enhanced the features and functionalities of the Cardiac Intelligence^™ platform to assist physicians in delivering superior and timely treatment for all heart conditions. Moving forward, the company wants to further expand the capabilities of its platform and integrate with more healthcare systems, thereby ensuring a significant improvement in the screening, recommendation, and management of cardiac diseases.